combating 'financial toxicity' - her2 biosimilars and combinations with chemotherapy.mp4
Published 7 years ago • 30 plays • Length 4:37Download video MP4
Download video MP3
Similar videos
-
4:34
her2 cancer treatment - resistance, immunologic implications, and biosimilars.mp4
-
3:01
her2 biosimilars in clinical practice - an interview with dr. william gradishar.mp4
-
7:46
practical considerations in integrating her2 biosimilars in clinical practice
-
3:39
biosimilars for her2-targeted antibodies
-
3:39
biosimilars for her2-targeted antibodies
-
4:27
her2 cancer treatment - resistance, immunologic implications, and biosimilars
-
1:50
findings of a biosimilar trastuzumab study in patients with her2-positive breast cancer
-
1:01:35
her2 treatment
-
0:59
dr. hope rugo on safety of trastuzumab biosimilar for her2 breast cancer
-
3:03
phase ii trial of patritumab deruxtecan in metastatic breast cancer
-
1:05
biosimilar trastuzumab: a cost effective alternative for breast cancer treatment
-
5:09
the use of biosimilars in her2 breast cancer
-
1:07
what are her2 cells?
-
0:59
dr. verma discusses biosimilars for trastuzumab
-
1:13
significance of the monarch 2 findings for abemaciclib in hr /her2- breast cancer
-
3:49
novel strategies for her2 metastatic breast cancer; biosimilars
-
16:58
assessing immune biomarkers of response to anthracyclines in breast cancer
-
1:31
dr. pegram on margetuximab plus chemo in her2 breast cancer
-
2:06
mylan biosimilar as good as herceptin in advanced breast cancer